12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Deals

AdeTherapeutics, Royal DSM deal

Royal DSM will use its polyesteramide biomaterial technology to develop AdeTherapeutics preclinical products for scar...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >